p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.
- DOI
- 10.1016/j.ctrv.2026.103212
- Published
- 2026 Sep 11
- Container
- Cancer treatment reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctrv.2026.103212,
title = {p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.},
author = {Etessami JD and Attili I and Aliaga PT and Cavallone M and Giordano E and Napoli VM and Del Signore E and Spitaleri G and Curigliano G and Passaro A},
year = {2026},
journal = {Cancer treatment reviews},
doi = {10.1016/j.ctrv.2026.103212},
url = {https://doi.org/10.1016/j.ctrv.2026.103212}
}RIS
TY - JOUR TI - p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications. AU - Etessami JD AU - Attili I AU - Aliaga PT AU - Cavallone M AU - Giordano E AU - Napoli VM AU - Del Signore E AU - Spitaleri G AU - Curigliano G AU - Passaro A PY - 2026 JO - Cancer treatment reviews DO - 10.1016/j.ctrv.2026.103212 UR - https://doi.org/10.1016/j.ctrv.2026.103212 ER -
APA
JD, E., I, A., PT, A., M, C., E, G., VM, N., E, D. S., G, S., G, C., & A, P. (2026). p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.. Cancer treatment reviews. https://doi.org/10.1016/j.ctrv.2026.103212
Source records
- pubmed · retrieved 2026-09-26T19:39:28.053Z